Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
CORRECTING and REPLACING Synergy Pharmaceuticals to Present at Upcoming September Investor Conferences
-
Synergy Pharmaceuticals to Present at Upcoming September Investor Conferences
-
Synergy Pharma (SGYP): Trulance IBS-C sNDA Accepted - Cantor
-
Pre-Open Movers 06/02: (LULU) (SGYP) (AVGO) Higher; (RH) (BOOT) (SVRA) Lower (more...)
-
After-Hours Stock Movers 06/01: (LULU) (SGYP) (AVGO) Higher; (RH) (BOOT) (ZUMZ) Lower (more...)
-
UPDATE: Cantor Fitzgerald Starts Synergy Pharmaceuticals (SGYP) at Overweight
-
Synergy Pharma (SGYP) Prices 20.3M Shares at $6.15
-
Synergy Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
After-Hours Stock Movers 01/31: (OSTK) (XOMA) (AAPL) Higher; (CATB) (SGYP) (BOOT) Lower (more...)
-
Synergy Pharma (SGYP) to Offer $125M in Common Stock
-
Synergy Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Synergy Pharmaceuticals to Present at the Cantor Fitzgerald Healthcare Conference
-
Streetinsider.com's Hot Lunchtime Reads 6/17: (TWTR) (EEI) (VOD) (SGYP)
-
Synergy (SGYP) Seen as Attractive Takeout Target at Cantor Fitzgerald; PT Up to $14
-
Synergy Pharmaceuticals Reports 2015 First Quarter Results and Business Update
-
Synergy Pharma (SGYP) Posts Q1 Loss of 18c/Share
-
Cantor Lower Price Target on Synergy (SGYP); Maintains Buy
-
Synergy Pharmaceuticals (SGYP) PT Nearly Doubled at Cantor Fitzgerald
-
Notable Analyst Rating Changes 09/25: (SWY) (GFI) (TIVO) Upgraded; (PAYX) (LEN) (ADP) Downgraded
-
Cantor Fitzgerald Starts Synergy Pharmaceuticals (SGYP) at Buy

